 |
인쇄하기
취소
|
Oscotec wins Europe patent for BT-201 for treatment of arthritis
Oscotec Inc., a local bone-related biopharmaceutical company, said on March 10 that it has recently won a patent of its anti-arthritis drug, BT-201, from the European Patent Office for the treatment of arthritis
The company said BT-201 is derived from natural substances to help regenerate cartilage and improve a bone density.
In order to make BT-201 worldwide medicine, patent registration...
The company said BT-201 is derived from natural substances to help regenerate cartilage and improve a bone density.
In order to make BT-201 worldwide medicine, patent registration...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.